Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NCT: NCT05902871 · ACTIVE_NOT_RECRUITING

NCT IDNCT05902871
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-11
SponsorBelkinVision (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑